p38 MAP kinase mediates stress‐induced internalization of EGFR: implications for cancer chemotherapy

[1]  S. Winograd-Katz,et al.  Cisplatin induces PKB/Akt activation and p38MAPK phosphorylation of the EGF receptor , 2006, Oncogene.

[2]  R. Puertollano,et al.  Activation of p38 Mitogen-Activated Protein Kinase Promotes Epidermal Growth Factor Receptor Internalization , 2006, Traffic.

[3]  M. Zerial,et al.  Phosphorylation of EEA1 by p38 MAP kinase regulates μ opioid receptor endocytosis , 2005, The EMBO journal.

[4]  J. Baselga,et al.  Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  J. Baselga,et al.  Critical update and emerging trends in epidermal growth factor receptor targeting in cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Y. Yarden,et al.  Synergistic down-regulation of receptor tyrosine kinases by combinations of mAbs: implications for cancer immunotherapy. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[7]  A. Ullrich,et al.  Oxidative and Osmotic Stress Signaling in Tumor Cells Is Mediated by ADAM Proteases and Heparin-Binding Epidermal Growth Factor , 2004, Molecular and Cellular Biology.

[8]  M. Oksvold,et al.  UV-Radiation-Induced Internalization of the Epidermal Growth Factor Receptor Requires Distinct Serine and Tyrosine Residues in the Cytoplasmic Carboxy-Terminal Domain , 2004, Radiation research.

[9]  Y. Yarden,et al.  Role of protein ubiquitylation in regulating endocytosis of receptor tyrosine kinases , 2004, Oncogene.

[10]  S. Y. Cajal,et al.  Role of the p38 MAPK pathway in cisplatin-based therapy , 2003, Oncogene.

[11]  H Steven Wiley,et al.  Trafficking of the ErbB receptors and its influence on signaling. , 2003, Experimental cell research.

[12]  A. Levitzki,et al.  Cisplatin-induced activation of the EGF receptor , 2002, Oncogene.

[13]  K. Carraway,et al.  Epidermal Growth Factor Receptor Activation under Oxidative Stress Fails to Promote c-Cbl Mediated Down-regulation* , 2002, The Journal of Biological Chemistry.

[14]  A. Citri,et al.  Drug‐induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapy , 2002, The EMBO journal.

[15]  Lee M Ellis,et al.  Enhanced antitumor activity of anti-epidermal growth factor receptor monoclonal antibody IMC-C225 in combination with irinotecan (CPT-11) against human colorectal tumor xenografts. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  E. Skarpen,et al.  UV induces tyrosine kinase-independent internalisation and endosome arrest of the EGF receptor. , 2002, Journal of cell science.

[17]  J. Yodoi,et al.  Redox-sensitive Transactivation of Epidermal Growth Factor Receptor by Tumor Necrosis Factor Confers the NF-κB Activation* , 2001, The Journal of Biological Chemistry.

[18]  G. Fontanini,et al.  Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  A. Ullrich,et al.  The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification. , 2001, Endocrine-related cancer.

[20]  M. Karin,et al.  The stress-induced MAP kinase p38 regulates endocytic trafficking via the GDI:Rab5 complex. , 2001, Molecular cell.

[21]  Y. Yarden,et al.  Untangling the ErbB signalling network , 2001, Nature Reviews Molecular Cell Biology.

[22]  M. Kris,et al.  Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[23]  Y. Yarden,et al.  Threonine Phosphorylation Diverts Internalized Epidermal Growth Factor Receptors from a Degradative Pathway to the Recycling Endosome* , 2000, The Journal of Biological Chemistry.

[24]  G. Tortora,et al.  Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[25]  A Ciechanover,et al.  Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. , 1999, Molecular cell.

[26]  Michael Karin,et al.  Ultraviolet Light and Osmotic Stress: Activation of the JNK Cascade Through Multiple Growth Factor and Cytokine Receptors , 1996, Science.

[27]  L. Norton,et al.  Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies. , 1993, Journal of the National Cancer Institute.

[28]  R. Bast,et al.  Requirements for the internalization of a murine monoclonal antibody directed against the HER-2/neu gene product c-erbB-2. , 1991, Cancer research.

[29]  J. Saklatvala,et al.  Down-modulation of epidermal growth factor receptor affinity in fibroblasts treated with interleukin 1 or tumor necrosis factor is associated with phosphorylation at a site other than threonine 654. , 1990, The Journal of biological chemistry.

[30]  J. Saklatvala,et al.  IL-1 and TNF transmodulate epidermal growth factor receptors by a protein kinase C-independent mechanism. , 1989, Journal of immunology.